Search

everythinglearnresearchcommunity

for

Search:↓

New cell-based therapies may improve hair loss treatments in the future.

Hair loss is common and requires proper diagnosis and treatment to address its causes and effects.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Infliximab may cause hair loss in Crohn's disease patients.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Unsatisfactory hair restoration results can be significantly improved with strategic hair redistribution and new donor hair placement, despite previous surgery challenges.

Flap surgery is effective for treating male baldness, offering immediate results with dense hair growth.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Frequent use of hair straighteners can cause hair loss similar to scarring alopecia in young Turkish women.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

The treatment improved hair growth and scalp health safely but needs more testing.

Trichoscopy is useful for diagnosing and assessing androgenetic alopecia severity.

Biofibre ® 4.0 hair implants are safe and satisfy most patients with hair loss.

Botulinum toxin may improve hair transplant results by enhancing graft survival and hair density.

Resveratrol-loaded carriers may help reduce hair loss from chemotherapy when used with scalp cooling.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Topical minoxidil increases hair density in androgenetic alopecia but has unclear clinical significance.

Fibrosing alopecia can be diagnosed without typical signs of lichen planopilaris.

Combining supplements with minoxidil improves hair growth more than minoxidil alone.

A new classification and scoring system is needed for alopecia areata to better assess severity.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

More effective treatments are needed for severe alopecia areata.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.